Gene Query: FGF1

Dataset Description Geneva Score
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 95.43
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 87.55
FOXP1 orchestration of ASD-relevant signaling pathways. 72.78
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 71.36
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 64.82
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 64.82
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 47.18
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 45.59
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 45.38
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 36.2
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 32.32
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 32.32
BET bromodomain inhibition 31.9
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 31.9
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 31.33
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 31.1
STRIPAK directs PP2A activity to promote oncogenic transformation 30.15
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 29.9
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 29.9
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 27.63
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 27.63
RNA-seq of stable and unstable section of human atherosclerotic plaques 26.32
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 25.06
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 25.06
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 23.14
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 23.13
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 22.56
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 20.21
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 19.92
Tumor exosome integrins determine organotropic metastasis 19.76
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 19.17
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 18.81
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 18.5
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 18.18
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 18.11
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 16.61
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 16.28
Real-time observation of light-controlled transcription in living cells 15.97
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 15.56
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 15.12
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 14.91
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 14.53
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 14.36
Single cell transcriptome of peritoneal cells 14.08
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 14.08
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 14.04
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 13.7
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 13.63
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 13.63
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 13.44
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 12.97
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 12.78
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 12.71
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 12.62
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 12.46
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 12.14
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 12.09
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 12.05
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 11.96
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 11.96
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 11.82
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 11.68
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 11.66
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 11.02
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 11.01
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 11.01
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 11.0
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.76
Nucleoporin-mediated regulation of cell identity genes 10.53
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 10.45
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 10.45
Regulation of Lipids is Central to Replicative Senescence 10.42
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 10.27
Small-molecule targeting of brachyury transcription factor addiction in chordoma 10.19
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 10.16
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 9.76
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 9.59
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 9.47
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 9.21
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 8.88
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 8.72
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 8.72
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 8.26
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 8.24
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 8.13
Transcriptomic profile of human embryonic renal corpuscles 8.07
CDK12 mediated transcriptional regulation in U2OS cells 8.04
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 8.03
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 8.02
Global epigenomic reconfiguration during mammalian brain development 7.96
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.85
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 7.78
Disruption of GRIN2B impairs differentiation in human neurons 7.56
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 7.45
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.44
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 7.43
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 7.0
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 7.0
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 6.94
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 6.88
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.79
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 6.71
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.71
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 6.7
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.64
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 6.62
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 6.62
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.62
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 6.62
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.56
RNA-sequencing of healthy human skeletal myocytes 6.5
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 6.46
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 6.46
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 6.43
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.29
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.21
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 6.07
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.04
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.0
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 5.97
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.68
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 5.66
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 5.61
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 5.59
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 5.59
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.57
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.54
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.49
hTERT promotes cell adhesion and migration independent of telomerase activity 5.46
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 5.45
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 5.45
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.42
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 5.42
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 5.42
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 5.38
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 5.38
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.28
Gene expression profile difference among renal location in a stone former 5.25
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 5.23
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.17
Redifferentiation of expanded human islet β cells by inhibition of ARX 5.14
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 5.12
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 5.1
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 5.05
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 5.0
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.99
NKX2.2 4.96
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.96
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.86
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 4.76
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.75
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.73
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 4.71
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 4.71
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 4.68
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 4.61
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.59
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.59
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.59
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.59
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 4.58
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 4.57
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 4.55
Dynamic reorganization of nuclear architecture during human cardiogenesis 4.48
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 4.48
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.44
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.44
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.43
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 4.41
RNA-seq of shEZH2 cells 4.38
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 4.37
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.32
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.31
The age and genomic integrity of neurons after cortical stroke in humans 4.29
R430: A potent inbibitor of DNA and RNA viruses 4.21
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 4.16
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 4.12
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 4.11
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 4.1
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.09
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.04
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.0
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.0
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 3.95
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.87
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.87
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.87
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.87
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 3.85
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.82
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 3.79
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.76
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 3.67
RNA-seq of human aneuploid cell lines with Trisomy 21 3.63
Investigation about fibroblasts of different origins in culture 3.61
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.56
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 3.46
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 3.45
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 3.42
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.39
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.36
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.23
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 3.2
Evolution of a transcriptional regulator from a transmembrane nucleoporin 3.18
RNA-seq in HepG2 and IMR90 cells 3.18
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.17
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 3.17
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 3.16
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.12
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 3.1
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.09
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 3.06
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.04
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.04
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.04
CUREfast: Accelerating research with families 3.03
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 3.03
Neurofibroma 3.03
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 2.99
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 2.99
Activity-dependent transcriptional changes in human neurons 2.99
circRNA-sequencing 2.97
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.96
MRTF activates TEAD-YAP target gene expression 2.92
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.87
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.82
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 2.81
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 2.81
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.79
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.79
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 2.78
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 2.74
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 2.73
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.73
RNA Sequencing of Human iPS derived Cardiomyocytes 2.72
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.71
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.69
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.68
mRNA-Seq profiling of human developing kidney 2.67
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.64
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 2.63
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 2.63
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 2.63
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.61
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.55
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.53
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.42
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 2.4
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.38
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.34
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 2.32
RNA-seq of cells with TET1 knockout 2.3
IL-33 activates tumor stroma to promote intestinal polyposis 2.28
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.28
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 2.25
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.24
RNA-seq of young and quiescent MRC-5 human fibroblasts 2.24
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 2.24
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.2
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 2.15
Functional astrocytes differentiated from hiPSCs 2.14
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.13
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.13
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.13
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 2.12
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.11
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 2.11
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 2.11
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.1
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.09
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.09
RNAseq in Alzheimer's Disease patients 2.06
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.05
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 2.04
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 2.03
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 2.03
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.02
Universal alternative splicing of noncoding exons 2.01
Differential analysis of gene regulation at transcript resolution by RNA-Seq 2.0
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 2.0
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.99
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 1.99
Tyrosine Kinase Inhibitor Cardiotoxicity 1.99
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.98
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.97
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 1.96
RNA-seq of tumor cells following angiopellosis extravasation 1.95
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.95
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.94
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.92
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.92
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.91
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.91
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.89
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.89
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.88
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.86
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.85
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 1.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.84
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.82
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.82
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 1.81
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 1.81
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 1.8
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.8
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.8
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.79
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 1.77
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.76
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 1.75
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 1.75
MicroRNA targetome analysis during HCMV infection 1.74
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.73
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.71
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.71
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.71
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.71
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.71
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 1.71
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 1.71
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.7
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.7
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 1.69
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 1.68
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 1.67
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.66
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 1.65
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.65
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.64
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.64
6mer seed toxicity in tumour suppressive microRNAs 1.63
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.62
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.62
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.61
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.61
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.61
Gene expression profiling of human and murine in vitro muscle differentiation 1.6
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 1.6
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.56
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.56
Gene profiling of human adult and pediatric liver cancer cells 1.56
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 1.54
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.53
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.53
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.53
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.52
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.52
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.52
Identification of differentially expressed genes between senescence and senescence bypass cells 1.49
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.48
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.47
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.46
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.46
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.45
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.43
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.43
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.42
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.42
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.42
Identification of expressed and conserved human non-coding RNAs 1.41
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.4
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.4
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 1.39
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.39
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.39
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.39
Regionally specified human pluripotent stem cell-derived astrocytes 1.37
Transcriptome analysis of kidney organoids 1.37
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 1.34
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.3
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.29
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.27
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.26
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 1.26
Transcriptomic analysis of LSD1 1.24
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.21
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.21
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 1.21
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.19
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 1.18
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 1.17
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.15
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 1.14
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.14
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.12
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.12
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.12
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.12
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 1.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.06
The human blood-nerve barrier transcriptome 1.05
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.05
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 1.05
Dilated cardiomyopathy vs Myocarditis 1.04
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.03
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.03
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.03
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.02
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 1.02
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 1.01
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 1.0
The cohesin complex prevents Myc-induced replication stress 0.96
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.94
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.91
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.9
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.9
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 0.89
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 0.87
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 0.87
Repurposing of promoters and enhancers during mammalian evolution 0.85
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.84
Effects of transcription on genome - nuclear lamina interactions 0.84
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.8
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.79
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.79
Primary human trophoblast from term placenta 0.78
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.77
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.77
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.75
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.75
Gene expression of collecting duct carcinoma of the kidney 0.73
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.72
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.71
iPSC-Derived Cholangiocytes 0.68
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.66
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.64
p53 activity results in DNA replication fork processivity 0.61
BMS-470539 on human synovial fibroblasts 0.61
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.6
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.59
The Glioma-Infiltrating T Cell Receptor Repertoire 0.58
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.57
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.57
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.55
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.55
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.55
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.54
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.45
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.44
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.43
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.43
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.42
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.42
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.41
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.41
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.38
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.38
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.37
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.37
Differential responses of human fetal brain neural stem cells to Zika virus infection 0.36
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.34
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.34
RNA-seq analysis upon ARID1B overexpression 0.34
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 0.34
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.33
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.33
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.33
Regulation of hypoxia-inducible factor activity by ZMYND8 0.32
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.31
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.3
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 0.3
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 0.26
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.26
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.26
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 0.24
Gene expression of thyroid cancer cell lines 0.22
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.22
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.22
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.19
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 0.19
Patient-derived xenograft platform for metastatic melanoma 0.18
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.16
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.16
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.14
Expression profiling of converted and control dermal BJ fibroblasts 0.13
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.13
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.12
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 0.12
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.11
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.11
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.09
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.09
RNA-Seq and expression data from human adipose tissue 0.09
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.09
Noncoding regions are the main source of targetable tumor-specific antigens 0.08
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.07
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 0.07
RNA-seq in endometrial stromal tumors 0.07
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.07
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.06
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.06
Investigate A2M treatment on human prostate cancer and mouse liver 0.05
Investigate A2M treatment on human prostate cancer xenograft in mice 0.05
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.04
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.03
The transcriptome of Kawasaki Disease arteritis 0.02
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation